AI assistant
Sending…
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2018
Mar 20, 2018
31580_dirs_2018-03-20_ada96b80-43ca-4c79-95a3-868398987124.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2018-03-16
Reporting Person: Scadden David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-16 | Common stock | P | 200 | $83.44 | Acquired | 571 | Direct |
More from AGIOS PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3